INTER-ETHNIC DIFFERENCES IN TOLERANCE OF ANTI-CANCER DRUGS

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/512533

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

In 2 previous studies we have shown that Asian cancer patients experience more side-effects than their Caucasian counterparts when treated with the same dose and schedule of treatment. This does not appear to be related to any difference in size. We wish to explain this difference as it may avoid Asian patients receiving overdoses of treatment. Possible causes include dietary and nutritional differences

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $345,894.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical biochemistry - inorganic elements and compounds

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Anti-cancer drug | Chemotherapy toxicity | Inter-ethnic differences | Nutrition | Nutrition status | Pharmacogenomics | Pharmacokinetics | Pharmacology-toxicology | Phenotype-genotype correlation

Related Links